Your browser doesn't support javascript.
loading
Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial.
Park, Seonyoung; Kim, Ah-Young; Cho, Hyeonseok; Baik, Deborah; Lee, Hankil; Cho, Sunghwa; Kang, Hye-Young.
Afiliação
  • Park S; Department of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea.
  • Kim AY; Department of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea.
  • Cho H; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea.
  • Baik D; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea.
  • Lee H; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea.
  • Cho S; Graduate School of Public Health, Yonsei University, Seoul, South Korea.
  • Kang HY; Institute of Health Services Research, Yonsei University, Seoul, South Korea.
BMC Cancer ; 20(1): 1157, 2020 Nov 26.
Article em En | MEDLINE | ID: mdl-33243162
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Aminopterina Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Aminopterina Idioma: En Ano de publicação: 2020 Tipo de documento: Article